Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01837069 · ClinicalTrials.gov registry record · Phase 4

Risk Factor Control Before Orthopedic Surgery

A Phase 4 study, sponsored by NYU Langone Health.

Terminated
Registry status
Phase 4
Development phase
198
Enrollment target

NCT01837069: Clinical Trial Phase 4 study, sponsored by NYU Langone Health.

NCT01837069 is a Phase 4 study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 198 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01837069, a Phase 4 study, was terminated before completion, sponsored by NYU Langone Health.

TERMINATED
Registry status
Phase 4
Development phase
198 participants
Enrollment target

Study Summary

This trial is designed to determine the best preoperative management strategy for patients undergoing orthopedic surgery.

Interventions

  • DRUG Atorvastatin
  • DRUG Metoprolol
  • DRUG Lisinopril
  • BEHAVIORAL Lifestyle counseling

Trial Details

FieldValue
Enrollment Target 198 participants
Start Date 2014-02
Est. Completion 2018-04-02
Phase Phase 4
NYU Langone Health

1,164 total trials

Why NCT01837069 stopped before completion

NCT01837069 is an interventional study that assigns participants to a tested intervention. The registered 198 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (62% lower).

The record links to 0 conditions, and to 4 interventions - of which Atorvastatin is the first listed.

NCT01837069 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01837069 about?

NCT01837069 is a clinical study titled "Risk Factor Control Before Orthopedic Surgery". This trial is designed to determine the best preoperative management strategy for patients undergoing orthopedic surgery.

What is the current status of trial NCT01837069?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 198 participants. The study started on 2014-02. Estimated completion is 2018-04-02.

What interventions are being tested in trial NCT01837069?

The interventions under investigation include: Atorvastatin (DRUG), Metoprolol (DRUG), Lisinopril (DRUG), Lifestyle counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT01837069?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01837069's enrollment target sits among peer trials

198 446th of 2000 higher than 1,553 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05203328 · 198 participants · NA

    Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy

  • NCT05426967 · 198 participants · NA

    rTMS for Military TBI-related Depression

  • NCT05561114 · 198 participants · Phase 3

    Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus

  • NCT05585190 · 198 participants · NA

    Stand Up for Your Health with a Sit-stand Desk

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01837069, the US trial registry maintained by the National Library of Medicine. NCT01837069 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.